Hydroxychloroquine-Induced QT Prolongation in a COVID-19-Positive Patient on Clozapine.

Amazan, Ralph; Gunturu, Sasidhar; Korenis, Panagiota

Amazan, Ralph; Gunturu, Sasidhar; Korenis, Panagiota.

Amazan R; Icahn School of Medicine, New York, New York.
Gunturu S; Corresponding author: Ralph Amazan, MD, 1276 Fulton Ave, 5th Floor South, Bronx, NY 10460 (ralphberdjomyamazan@gmail.com).
Korenis P; Icahn School of Medicine, New York, New York.

Prim Care Companion CNS Disord ; 24(5)2022 09 20.

Article in English | MEDLINE | ID: covidwho-2040079

Subject(s)

COVID-19 Drug Treatment; Clozapine; Long QT Syndrome; Clozapine/adverse effects; Humans; Hydroxychloroquine/adverse effects; Long QT Syndrome/chemically induced

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Long QT Syndrome / Clozapine / COVID-19 Drug Treatment Limits: Humans Language: English Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google